Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) EV/EBITDA Ratio: 13.73x
Is Labcorp Holdings Inc.’s EV/EBITDA ratio high or low?
Labcorp Holdings Inc.'s EV/EBITDA ratio of 13.73x is 17% above its 5-year average of 11.71x, near the high end of its 5-year range (5.46x–16.24x).
As of Monday, June 15, 2026. 6.52% below its 12-month average of 14.69x.
LH EV/EBITDA Ratio Chart
LH EV/EBITDA Ratio
13.73x-11.87% 1Y
Zoom
LH Average EV/EBITDA Ratio Chart
LH Current vs Average EV/EBITDA Ratio Chart
LH EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
13.73x
EV/EBITDA RATIO AVG TTM
14.69x
EV/EBITDA RATIO AVG 3Y
14.58x
EV/EBITDA RATIO AVG 5Y
11.71x
EV/EBITDA RATIO AVG 10Y
11.23x
EV/EBITDA RATIO AVG 15Y
10.50x
EV/EBITDA RATIO AVG 20Y
10.02x
CURRENT VS TTM AVG
-6.52%
CURRENT VS 3Y AVG
-5.85%
CURRENT VS 5Y AVG
+17.21%
CURRENT VS 10Y AVG
+22.21%
CURRENT VS 15Y AVG
+30.77%
CURRENT VS 20Y AVG
+37.08%
LH Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.69B | 13.73x | 14.69x | 14.58x | 11.71x |
| Moderna, Inc. (MRNA)vs › | $20.47B | N/A | 12.39x | 25.28x | 25.28x |
| BioNTech SE (BNTX)vs › | $22.96B | N/A | 51.40x | 19.63x | 20.05x |
| Mettler-Toledo International Inc. (MTD)vs › | $23.32B | 20.60x | 23.58x | 23.88x | 26.49x |
| Waters Corporation (WAT)vs › | $23.32B | 37.31x | 21.79x | 21.32x | 21.48x |
| United Therapeutics Corporation (UTHR)vs › | $23.33B | 14.51x | 11.93x | 10.21x | 11.38x |
| Veeva Systems Inc. (VEEV)vs › | $26.34B | 19.50x | 33.10x | 43.86x | 53.92x |
| Hologic, Inc. (HOLX)vs › | $16.97B | 17.28x | 15.01x | 15.35x | 12.41x |
| DexCom, Inc. (DXCM)vs › | $28.52B | 20.28x | 25.32x | 42.50x | 70.63x |
| Biogen Inc. (BIIB)vs › | $29.22B | 12.16x | 8.71x | 11.20x | 12.24x |
EV/EBITDA vs. its own history
At 13.7, EV/EBITDA is richer than usual, sitting higher than 85% of its 20-year history.
20-year low
5.5
median
9.6
20-year high
17.2
cheaperricher
Labcorp Holdings Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Labcorp Holdings Inc. (LH)?
- The EV/EBITDA ratio for LH stock is 13.73x.
- Is Labcorp Holdings Inc.'s EV/EBITDA ratio high or low?
- Labcorp Holdings Inc.'s EV/EBITDA ratio of 13.73x is 17% above its 5-year average of 11.71x, near the high end of its 5-year range (5.46x–16.24x).
- What is the TTM average EV/EBITDA ratio for Labcorp Holdings Inc. (LH)?
- The TTM average EV/EBITDA ratio for LH stock is 14.69x.
- What is the 3Y average EV/EBITDA ratio for Labcorp Holdings Inc. (LH)?
- The 3Y average EV/EBITDA ratio for LH stock is 14.58x.
- What is the 5Y average EV/EBITDA ratio for Labcorp Holdings Inc. (LH)?
- The 5Y average EV/EBITDA ratio for LH stock is 11.71x.
- What is the 10Y average EV/EBITDA ratio for Labcorp Holdings Inc. (LH)?
- The 10Y average EV/EBITDA ratio for LH stock is 11.23x.
- What is the 15Y average EV/EBITDA ratio for Labcorp Holdings Inc. (LH)?
- The 15Y average EV/EBITDA ratio for LH stock is 10.50x.
- What is the 20Y average EV/EBITDA ratio for Labcorp Holdings Inc. (LH)?
- The 20Y average EV/EBITDA ratio for LH stock is 10.02x.
Labcorp Holdings Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-12 | 13.73x |
| 2026-06-11 | 13.70x |
| 2026-06-10 | 13.83x |
| 2026-06-09 | 13.94x |
| 2026-06-08 | 13.56x |
| 2026-06-05 | 13.69x |
| 2026-06-04 | 13.52x |
| 2026-06-03 | 13.44x |
| 2026-06-02 | 13.39x |
| 2026-06-01 | 13.36x |
| 2026-05-29 | 13.49x |
| 2026-05-28 | 13.59x |
| 2026-05-27 | 13.41x |
| 2026-05-26 | 13.42x |
| 2026-05-22 | 13.48x |
| 2026-05-21 | 13.31x |
| 2026-05-20 | 13.38x |
| 2026-05-19 | 13.23x |
| 2026-05-18 | 13.31x |
| 2026-05-15 | 13.10x |
| 2026-05-14 | 13.24x |
| 2026-05-13 | 13.26x |
| 2026-05-12 | 13.38x |
| 2026-05-11 | 13.29x |
| 2026-05-08 | 13.25x |
| 2026-05-07 | 13.41x |
| 2026-05-06 | 13.36x |
| 2026-05-05 | 13.37x |
| 2026-05-04 | 13.20x |
| 2026-05-01 | 13.89x |
| 2026-04-30 | 13.93x |
| 2026-04-29 | 13.95x |
| 2026-04-28 | 14.05x |
| 2026-04-27 | 14.21x |
| 2026-04-24 | 14.22x |
| 2026-04-23 | 14.27x |
| 2026-04-22 | 14.59x |
| 2026-04-21 | 14.62x |
| 2026-04-20 | 14.44x |
| 2026-04-17 | 14.51x |
| 2026-04-16 | 14.33x |
| 2026-04-15 | 14.34x |
| 2026-04-14 | 14.43x |
| 2026-04-13 | 14.24x |
| 2026-04-10 | 14.10x |
| 2026-04-09 | 14.61x |
| 2026-04-08 | 14.67x |
| 2026-04-07 | 14.44x |
| 2026-04-06 | 14.66x |
| 2026-04-02 | 14.63x |
| 2026-04-01 | 14.59x |
| 2026-03-31 | 14.35x |
| 2026-03-30 | 14.21x |
| 2026-03-27 | 14.24x |
| 2026-03-26 | 14.41x |
| 2026-03-25 | 14.31x |
| 2026-03-24 | 14.32x |
| 2026-03-23 | 14.25x |
| 2026-03-20 | 14.19x |
| 2026-03-19 | 14.23x |
| 2026-03-18 | 14.31x |
| 2026-03-17 | 14.50x |
| 2026-03-16 | 14.35x |
| 2026-03-13 | 14.22x |
| 2026-03-12 | 14.19x |
| 2026-03-11 | 14.50x |
| 2026-03-10 | 14.42x |
| 2026-03-09 | 14.63x |
| 2026-03-06 | 14.46x |
| 2026-03-05 | 14.72x |
| 2026-03-04 | 14.93x |
| 2026-03-03 | 15.02x |
| 2026-03-02 | 15.16x |
| 2026-02-27 | 15.27x |
| 2026-02-26 | 15.21x |
| 2026-02-25 | 15.01x |
| 2026-02-24 | 15.19x |
| 2026-02-23 | 15.16x |
| 2026-02-20 | 15.05x |
| 2026-02-19 | 15.04x |
| 2026-02-18 | 14.89x |
| 2026-02-17 | 14.80x |
| 2026-02-13 | 15.05x |
| 2026-02-12 | 14.86x |
| 2026-02-11 | 15.35x |
| 2026-02-10 | 15.13x |
| 2026-02-09 | 14.69x |
| 2026-02-06 | 14.82x |
| 2026-02-05 | 14.87x |
| 2026-02-04 | 14.78x |
| 2026-02-03 | 14.62x |
| 2026-02-02 | 14.54x |
| 2026-01-30 | 14.59x |
| 2026-01-29 | 14.52x |
| 2026-01-28 | 14.44x |
| 2026-01-27 | 14.57x |
| 2026-01-26 | 14.42x |
| 2026-01-23 | 14.39x |
| 2026-01-22 | 14.52x |
| 2026-01-21 | 14.49x |
| 2026-01-20 | 14.58x |
| 2026-01-16 | 14.56x |
| 2026-01-15 | 14.48x |
| 2026-01-14 | 14.19x |
| 2026-01-13 | 13.86x |
| 2026-01-12 | 13.71x |
| 2026-01-09 | 13.77x |
| 2026-01-08 | 13.89x |
| 2026-01-07 | 13.85x |
| 2026-01-06 | 14.13x |
| 2026-01-05 | 13.83x |
| 2026-01-02 | 13.76x |
| 2025-12-31 | 13.73x |
| 2025-12-30 | 13.82x |
| 2025-12-29 | 13.82x |
| 2025-12-26 | 13.85x |
| 2025-12-24 | 13.88x |
| 2025-12-23 | 13.82x |
| 2025-12-22 | 13.90x |
| 2025-12-19 | 13.78x |
| 2025-12-18 | 13.78x |
| 2025-12-17 | 13.93x |
| 2025-12-16 | 14.03x |
| 2025-12-15 | 14.25x |
| 2025-12-12 | 14.28x |
| 2025-12-11 | 14.31x |
| 2025-12-10 | 14.19x |
| 2025-12-09 | 14.03x |
| 2025-12-08 | 14.11x |
| 2025-12-05 | 14.04x |
| 2025-12-04 | 14.17x |
| 2025-12-03 | 14.35x |
| 2025-12-02 | 14.36x |
| 2025-12-01 | 14.43x |
| 2025-11-28 | 14.47x |
| 2025-11-26 | 14.45x |
| 2025-11-25 | 14.52x |
| 2025-11-24 | 14.33x |
| 2025-11-21 | 14.34x |
| 2025-11-20 | 14.17x |
| 2025-11-19 | 14.13x |
| 2025-11-18 | 14.10x |
| 2025-11-17 | 14.17x |
| 2025-11-14 | 14.40x |
| 2025-11-13 | 14.44x |
| 2025-11-12 | 14.36x |
| 2025-11-11 | 14.45x |
| 2025-11-10 | 14.16x |
| 2025-11-07 | 13.81x |
| 2025-11-06 | 13.55x |
| 2025-11-05 | 13.72x |
| 2025-11-04 | 13.79x |
| 2025-11-03 | 14.02x |
| 2025-10-31 | 13.86x |
| 2025-10-30 | 14.50x |
| 2025-10-29 | 14.31x |
| 2025-10-28 | 14.83x |
| 2025-10-27 | 15.55x |
| 2025-10-24 | 15.72x |
| 2025-10-23 | 15.92x |
| 2025-10-22 | 15.87x |
| 2025-10-21 | 15.93x |
| 2025-10-20 | 16.23x |
| 2025-10-17 | 16.01x |
| 2025-10-16 | 15.91x |
| 2025-10-15 | 15.87x |
| 2025-10-14 | 15.73x |
| 2025-10-13 | 15.59x |
| 2025-10-10 | 15.65x |
| 2025-10-09 | 15.64x |
| 2025-10-08 | 15.63x |
| 2025-10-07 | 15.73x |
| 2025-10-06 | 15.52x |
| 2025-10-03 | 15.61x |
| 2025-10-02 | 15.72x |
| 2025-10-01 | 15.70x |
| 2025-09-30 | 16.06x |
| 2025-09-29 | 15.87x |
| 2025-09-26 | 15.77x |
| 2025-09-25 | 15.57x |
| 2025-09-24 | 15.71x |
| 2025-09-23 | 15.74x |
| 2025-09-22 | 15.69x |
| 2025-09-19 | 15.62x |
| 2025-09-18 | 15.62x |
| 2025-09-17 | 15.57x |
| 2025-09-16 | 15.48x |
| 2025-09-15 | 15.54x |
| 2025-09-12 | 15.65x |
| 2025-09-11 | 15.73x |
| 2025-09-10 | 15.43x |
| 2025-09-09 | 15.66x |
| 2025-09-08 | 15.62x |
| 2025-09-05 | 15.68x |
| 2025-09-04 | 15.53x |
| 2025-09-03 | 15.47x |
| 2025-09-02 | 15.46x |
| 2025-08-29 | 15.65x |
| 2025-08-28 | 15.53x |
| 2025-08-27 | 15.71x |
| 2025-08-26 | 15.67x |
| 2025-08-25 | 15.57x |
| 2025-08-22 | 15.66x |
| 2025-08-21 | 15.59x |
| 2025-08-20 | 15.66x |
| 2025-08-19 | 15.55x |
| 2025-08-18 | 15.32x |
| 2025-08-15 | 15.31x |
| 2025-08-14 | 15.35x |
| 2025-08-13 | 15.41x |
| 2025-08-12 | 15.26x |
| 2025-08-11 | 15.19x |
| 2025-08-08 | 15.11x |
| 2025-08-07 | 14.84x |
| 2025-08-06 | 14.88x |
| 2025-08-05 | 15.00x |
| 2025-08-04 | 15.02x |
| 2025-08-01 | 14.91x |
| 2025-07-31 | 15.51x |
| 2025-07-30 | 15.69x |
| 2025-07-29 | 15.58x |
| 2025-07-28 | 15.59x |
| 2025-07-25 | 15.73x |
| 2025-07-24 | 15.86x |
| 2025-07-23 | 15.06x |
| 2025-07-22 | 15.13x |
| 2025-07-21 | 14.71x |
| 2025-07-18 | 14.74x |
| 2025-07-17 | 14.91x |
| 2025-07-16 | 14.85x |
| 2025-07-15 | 14.83x |
| 2025-07-14 | 15.03x |
| 2025-07-11 | 15.02x |
| 2025-07-10 | 15.21x |
| 2025-07-09 | 15.46x |
| 2025-07-08 | 15.38x |
| 2025-07-07 | 15.40x |
| 2025-07-03 | 15.59x |
| 2025-07-02 | 15.50x |
| 2025-07-01 | 15.70x |
| 2025-06-30 | 15.62x |
| 2025-06-27 | 15.53x |
| 2025-06-26 | 15.36x |
| 2025-06-25 | 15.44x |
| 2025-06-24 | 15.62x |
| 2025-06-23 | 15.55x |
| 2025-06-20 | 15.59x |
| 2025-06-18 | 15.57x |
| 2025-06-17 | 15.48x |
| 2025-06-16 | 15.69x |
| 2025-06-13 | 15.56x |
| 2025-06-12 | 15.58x |
| 2025-06-11 | 15.50x |
| 2025-06-10 | 15.47x |
| 2025-06-09 | 15.30x |
| 2025-06-06 | 15.22x |
| 2025-06-05 | 15.14x |
| 2025-06-04 | 15.24x |
| 2025-06-03 | 15.06x |
| 2025-06-02 | 14.94x |
Showing the most recent 260 of 5,033 data points. The chart above shows the full history.
Related Metrics
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter